Market Overview:
The global biopharmaceuticals excipients market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for biopharmaceuticals and rising awareness about their benefits. In addition, the growing number of approvals for new drugs is also contributing to the growth of this market. Based on type, triglycerides accounted for the largest share of the global biopharmaceuticals excipients market in 2017. This segment is expected to continue its dominance during the forecast period due to its properties such as low toxicity and non-irritating nature. Based on application, oral formulations accounted for the largest share of the global biopharmaceuticals excipients market in 2017.
Product Definition:
A biopharmaceutical excipient is a substance that is not the active drug in a pharmaceutical product but is necessary to deliver or enhance the effectiveness of the drug. Excipients may be used to improve the stability, solubility, or manufacturability of a drug and may also play a role in patient safety by reducing potential side effects.
Triglycerides:
Triglycerides are lipids found in the blood and other body fluids. They are formed during fat digestion and used as an excipient in the formulation of various pharmaceutical drugs. The major function of triglycerides is to serve as a transport medium for active ingredients at the time of absorption from oral or parenteral administration routes.
Mannitol:
Mannitol is a type of sugar alcohol, which is also known as d-glucose. It has the ability to bind water and form hydrogels. Mannitol has been used in pharmaceuticals for many years as an excipient or filler in tablets and capsules owing to its low molecular weight (60), which results in ease of oral administration with no change in therapeutic action.
Application Insights:
Oral formulations held the largest revenue share in 2016 owing to the high consumption of biopharmaceuticals in oral form for clinical trials. The growing usage of biopharmaceuticals in cancer treatment, along with increasing R&D investments by companies, is expected to boost product demand.
The topical formulations segment is anticipated to witness lucrative growth over the forecast period due to extensive usage of benzene sulfonamide and polyethylene glycol 3350 as excipients for transdermal drug delivery systems. Increasing focus on new drug development and technological advancements are further expected to propel market growth over the coming years.
Regional Analysis:
North America accounted for the largest share of revenue in 2017 owing to the presence of a large number of biopharmaceutical manufacturers coupled with high R&D investment by companies operating within this region. The U.S. is considered as one of the most lucrative markets for excipients due to factors such as favorable government initiatives, availability and adoption rate of new technologies, and growing healthcare spending in this country.
Asia Pacific is expected to register significant growth over the forecast period owing to increasing R&D expenditure by pharmaceutical companies along with rising healthcare awareness among people pertaining to advanced therapies at affordable costs supported by innovative excipients used across various applications. This has resulted in increased demand from several end-use industries such as cosmetics & personal care; food & beverage; medical devices; nutraceuticals etc., which will further boost market growth over the coming years ( 28).
Growth Factors:
- Increasing demand for biopharmaceuticals due to rising prevalence of chronic diseases
- Growing number of biopharmaceuticals in development and approval process
- Rising demand from emerging markets
- Technological advancements in excipient production and formulation processes
- Increasing focus on quality by manufacturers
Scope Of The Report
Report Attributes
Report Details
Report Title
Biopharmaceuticals Excipients Market Research Report
By Type
Triglycerides, Mannitol, Sorbitol, Sucrose, Dextrose, Starch, Others
By Application
Oral Formulations, Topical Formulations, Parenteral Formulations, Other
By Companies
Dow, BASF, ER-KANG, JRS Pharma, Lubrizol, Ashland, Roquette, Shin-Etsu, Evonik, ABITEC Corp, Signet Chemical Corporation, Sigachi Industries, MEGGLE AG
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
189
Number of Tables & Figures
133
Customization Available
Yes, the report can be customized as per your need.
Global Biopharmaceuticals Excipients Market Report Segments:
The global Biopharmaceuticals Excipients market is segmented on the basis of:
Types
Triglycerides, Mannitol, Sorbitol, Sucrose, Dextrose, Starch, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oral Formulations, Topical Formulations, Parenteral Formulations, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Dow
- BASF
- ER-KANG
- JRS Pharma
- Lubrizol
- Ashland
- Roquette
- Shin-Etsu
- Evonik
- ABITEC Corp
- Signet Chemical Corporation
- Sigachi Industries
- MEGGLE AG
Highlights of The Biopharmaceuticals Excipients Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Triglycerides
- Mannitol
- Sorbitol
- Sucrose
- Dextrose
- Starch
- Others
- By Application:
- Oral Formulations
- Topical Formulations
- Parenteral Formulations
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biopharmaceuticals Excipients Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Biopharmaceuticals excipients are substances that are used in the formulation of biologics, such as proteins and vaccines. These substances help to improve the stability, potency, and delivery of these products.
Some of the major companies in the biopharmaceuticals excipients market are Dow, BASF, ER-KANG, JRS Pharma, Lubrizol, Ashland, Roquette, Shin-Etsu, Evonik, ABITEC Corp, Signet Chemical Corporation, Sigachi Industries, MEGGLE AG.
The biopharmaceuticals excipients market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biopharmaceuticals Excipients Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Biopharmaceuticals Excipients Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Biopharmaceuticals Excipients Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Biopharmaceuticals Excipients Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Biopharmaceuticals Excipients Market Size & Forecast, 2018-2028
4.5.1 Biopharmaceuticals Excipients Market Size and Y-o-Y Growth
4.5.2 Biopharmaceuticals Excipients Market Absolute $ Opportunity
Chapter 5 Global Biopharmaceuticals Excipients Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Biopharmaceuticals Excipients Market Size Forecast by Type
5.2.1 Triglycerides
5.2.2 Mannitol
5.2.3 Sorbitol
5.2.4 Sucrose
5.2.5 Dextrose
5.2.6 Starch
5.2.7 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Biopharmaceuticals Excipients Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Biopharmaceuticals Excipients Market Size Forecast by Applications
6.2.1 Oral Formulations
6.2.2 Topical Formulations
6.2.3 Parenteral Formulations
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Biopharmaceuticals Excipients Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Biopharmaceuticals Excipients Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Biopharmaceuticals Excipients Analysis and Forecast
9.1 Introduction
9.2 North America Biopharmaceuticals Excipients Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Biopharmaceuticals Excipients Market Size Forecast by Type
9.6.1 Triglycerides
9.6.2 Mannitol
9.6.3 Sorbitol
9.6.4 Sucrose
9.6.5 Dextrose
9.6.6 Starch
9.6.7 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Biopharmaceuticals Excipients Market Size Forecast by Applications
9.10.1 Oral Formulations
9.10.2 Topical Formulations
9.10.3 Parenteral Formulations
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Biopharmaceuticals Excipients Analysis and Forecast
10.1 Introduction
10.2 Europe Biopharmaceuticals Excipients Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Biopharmaceuticals Excipients Market Size Forecast by Type
10.6.1 Triglycerides
10.6.2 Mannitol
10.6.3 Sorbitol
10.6.4 Sucrose
10.6.5 Dextrose
10.6.6 Starch
10.6.7 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Biopharmaceuticals Excipients Market Size Forecast by Applications
10.10.1 Oral Formulations
10.10.2 Topical Formulations
10.10.3 Parenteral Formulations
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Biopharmaceuticals Excipients Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Biopharmaceuticals Excipients Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Biopharmaceuticals Excipients Market Size Forecast by Type
11.6.1 Triglycerides
11.6.2 Mannitol
11.6.3 Sorbitol
11.6.4 Sucrose
11.6.5 Dextrose
11.6.6 Starch
11.6.7 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Biopharmaceuticals Excipients Market Size Forecast by Applications
11.10.1 Oral Formulations
11.10.2 Topical Formulations
11.10.3 Parenteral Formulations
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Biopharmaceuticals Excipients Analysis and Forecast
12.1 Introduction
12.2 Latin America Biopharmaceuticals Excipients Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Biopharmaceuticals Excipients Market Size Forecast by Type
12.6.1 Triglycerides
12.6.2 Mannitol
12.6.3 Sorbitol
12.6.4 Sucrose
12.6.5 Dextrose
12.6.6 Starch
12.6.7 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Biopharmaceuticals Excipients Market Size Forecast by Applications
12.10.1 Oral Formulations
12.10.2 Topical Formulations
12.10.3 Parenteral Formulations
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Biopharmaceuticals Excipients Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Biopharmaceuticals Excipients Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Biopharmaceuticals Excipients Market Size Forecast by Type
13.6.1 Triglycerides
13.6.2 Mannitol
13.6.3 Sorbitol
13.6.4 Sucrose
13.6.5 Dextrose
13.6.6 Starch
13.6.7 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Biopharmaceuticals Excipients Market Size Forecast by Applications
13.10.1 Oral Formulations
13.10.2 Topical Formulations
13.10.3 Parenteral Formulations
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Biopharmaceuticals Excipients Market: Competitive Dashboard
14.2 Global Biopharmaceuticals Excipients Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Dow
14.3.2 BASF
14.3.3 ER-KANG
14.3.4 JRS Pharma
14.3.5 Lubrizol
14.3.6 Ashland
14.3.7 Roquette
14.3.8 Shin-Etsu
14.3.9 Evonik
14.3.10 ABITEC Corp
14.3.11 Signet Chemical Corporation
14.3.12 Sigachi Industries
14.3.13 MEGGLE AG
